HORMONE REPLACEMENT THERAPY AND BREAST CANCER – NEWS ANDRECOMMENDATION
BACKGROUND HT should be considered only when an indication for therapy has been clearly identified,contraindications ruled out, and the potential individual benefits and risks adequatelydiscussed with the women so that an informed decision can be made.Breast cancer risk increases with EPT use beyond...
| Main Authors: | , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Slovenian Medical Association
2008-12-01
|
| Series: | Zdravniški Vestnik |
| Online Access: | http://vestnik.szd.si/index.php/ZdravVest/article/view/848 |